SYNTARA LIMITED - Announcements

Market Cap $32.23M Add to my watchlist

Healthcare

Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug... Syntara Limited, formerly Pharmaxis Ltd, is an Australia-based clinical-stage drug development company with a focus on blood-related cancers. The Company’s highly productive drug discovery engine is driven by its expertise in amine oxidase inhibitors. Its lead candidate, PXS-5505, is used for the bone marrow cancer myelofibrosis, which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its PXS-4728 is a SSAO/MAOB inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis, and cardiac fibrosis. It has developed two respiratory products: Bronchitol, for cystic fibrosis, and Aridol, a lung function test.More

Announcements

Filter Results

All Price Sensitive Only

SNT	SNT to present in MST Access Hidden Gems Webinar		12/06/24	109.57KB	Share
SNT	Change of registry address notification		24/05/24	88.49KB	Share
SNT	Investor Webinar Presentation		17/05/24	107.34KB	Share
SNT	Application for quotation of securities - SNT		30/04/24	15.66KB	Share
SNT	Updated company investor presentation		30/04/24	938.01KB	Share
SNT	Presentation for quarterly shareholder briefing		30/04/24	430.76KB	Share
SNT	Quarterly Activities Report	PRICE SENSITIVE	30/04/24	201.7KB	Share
SNT	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	234.71KB	Share
SNT	Notification of cessation of securities - SNT		29/04/24	12.73KB	Share
SNT	SNT Quarterly Report and Investor Briefing		24/04/24	110.47KB	Share
SNT	Change in substantial holding		15/04/24	170.12KB	Share
SNT	Phase 2 Trial Reaches 50% Recruitment		10/04/24	123.17KB	Share
SNT	Investor presentation - NWR Virtual Healthcare Conference		19/03/24	903.3KB	Share
SNT	SNT to present at NWR Virtual Healthcare Conference		14/03/24	98.36KB	Share
SNT	Investor Presentation		06/03/24	1.19MB	Share
SNT	Change in substantial holding		04/03/24	665.93KB	Share
SNT	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/24	792.29KB	Share
SNT	Application for quotation of securities - SNT		29/02/24	15.67KB	Share
SNT	Change of Director's Interest Notice		14/02/24	224.17KB	Share
SNT	Change of Director's Interest Notice		14/02/24	225.86KB	Share
SNT	Notification regarding unquoted securities - SNT		14/02/24	19.03KB	Share
SNT	SNT to Trial New Cancer Indication Following MRFF Grant		14/02/24	117.23KB	Share
SNT	Change in substantial holding		09/02/24	201.17KB	Share
SNT	Application for quotation of securities - SNT		08/02/24	15.64KB	Share
SNT	Change in substantial holding		07/02/24	184.65KB	Share
SNT	Notification of cessation of securities - SNT		06/02/24	12.72KB	Share
SNT	Notification of cessation of securities - SNT		06/02/24	12.75KB	Share
SNT	Change of Director's Interest Notice		06/02/24	222.73KB	Share
SNT	Section 708A(5)9e) Notice		06/02/24	116.16KB	Share
SNT	Application for quotation of securities - SNT		06/02/24	15.33KB	Share
SNT	Application for quotation of securities - SNT		06/02/24	15.6KB	Share
SNT	Investor presentation - Euroz Hartley Healthcare Conference		06/02/24	920.77KB	Share
SNT	Security Purchase Plan		02/02/24	103.06KB	Share
SNT	Quarterly investor presentation		01/02/24	348.72KB	Share
SNT	Results of Meeting		31/01/24	188.24KB	Share
SNT	Quarterly Activities Report	PRICE SENSITIVE	31/01/24	343.15KB	Share
SNT	Quarterly Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	223.07KB	Share
SNT	Ceasing to be a substantial holder		23/01/24	218.61KB	Share
SNT	Change in substantial holding		04/01/24	272.5KB	Share
SNT	Change in substantial holding		03/01/24	272.41KB	Share
SNT	Application for quotation of securities - SNT		02/01/24	24.91KB	Share
SNT	Change in substantial holding		02/01/24	605.64KB	Share
SNT	Change in substantial holding		29/12/23	179.6KB	Share
SNT	Security Purchase Plan		29/12/23	645.88KB	Share
SNT	Notice of General Meeting/Proxy Form		29/12/23	4.15MB	Share
SNT	Section 708A(5)(e) Notice		27/12/23	397.23KB	Share
SNT	Application for quotation of securities - SNT		27/12/23	24.8KB	Share
SNT	Investor presentation - equity raising		19/12/23	1.6MB	Share
SNT	Proposed issue of securities - SNT		19/12/23	35.5KB	Share
SNT	Placement	PRICE SENSITIVE	19/12/23	367.31KB	Share
SNT	Trading Halt	PRICE SENSITIVE	18/12/23	399.59KB	Share
SNT	SNT doses first patient in Phase 2 combination MF trial		13/12/23	176KB	Share
SNT	Constitution		08/12/23	381.63KB	Share
SNT	Syntara Receives $5m R&D Tax Incentive		05/12/23	475.35KB	Share
SNT	Change of Company Name		04/12/23	471.76KB	Share
SNT	Change of Director's Interest Notice - GP		29/11/23	251.95KB	Share
SNT	Notification regarding unquoted securities - PXS		29/11/23	25.13KB	Share
SNT	Results of Meeting		28/11/23	353.47KB	Share
SNT	CEO Presentation to AGM		28/11/23	1.22MB	Share
SNT	Chair's Address to Shareholders		28/11/23	162.83KB	Share
SNT	Application for quotation of securities - PXS		13/11/23	24.91KB	Share
SNT	First patient dosed in Phase 2 trial of sleep disorder		09/11/23	493.58KB	Share
SNT	Application for quotation of securities - PXS		06/11/23	24.91KB	Share
SNT	Investor presentation - quarterly update		31/10/23	576.24KB	Share
SNT	Quarterly Activities Report	PRICE SENSITIVE	31/10/23	818.62KB	Share
SNT	Quarterly Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	402.52KB	Share
SNT	PXS Quarterly Shareholder Update and Investor Call		30/10/23	181.32KB	Share
SNT	Appendix 4G		26/10/23	253.7KB	Share
SNT	Corporate Governance Statement		26/10/23	232.32KB	Share
SNT	Annual Report to shareholders		26/10/23	1.26MB	Share
SNT	Notice of Annual General Meeting/Proxy Form		26/10/23	845.73KB	Share
SNT	Pharmaxis Completes Sale of Mannitol Business		19/10/23	183.67KB	Share
SNT	Investor Presentation		17/10/23	1.8MB	Share
SNT	Notification regarding unquoted securities - PXS		12/10/23	26.7KB	Share
SNT	Notification of cessation of securities - PXS		06/10/23	21.54KB	Share
SNT	Final Directors Interest Notice		03/10/23	115.8KB	Share
SNT	Final Directors Interest Notice		03/10/23	116.87KB	Share
SNT	Investor Presentation		03/10/23	1.65MB	Share
SNT	PXS Company Restructure Sale of Mannitol Business	PRICE SENSITIVE	03/10/23	498.47KB	Share
SNT	Trading Halt	PRICE SENSITIVE	02/10/23	556.33KB	Share
SNT	Date of Virtual AGM Date for Receipt of Director Nominations		13/09/23	225.94KB	Share
SNT	Application for quotation of securities - PXS		01/09/23	24.91KB	Share
SNT	Nature Cancer Publishes Results of PXS Garvin Collaboration		29/08/23	257.28KB	Share
SNT	Preliminary Final Report	PRICE SENSITIVE	28/08/23	2.05MB	Share
SNT	Change in substantial holding		14/08/23	647.58KB	Share
SNT	Application for quotation of securities - PXS		08/08/23	24.91KB	Share
SNT	Notification of cessation of securities - PXS		08/08/23	21.51KB	Share
SNT	PXS to Receive Prepayment of 2023 Research Tax Incentive	PRICE SENSITIVE	08/08/23	188.43KB	Share
SNT	Quarterly Activities Report	PRICE SENSITIVE	31/07/23	643.63KB	Share
SNT	Quarterly Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/23	330.79KB	Share
SNT	Pharmaxis Quarterly Shareholder Update and Investor Briefing		28/07/23	203.69KB	Share
SNT	Ceasing to be a substantial holder		26/07/23	85.16KB	Share
SNT	Investor Presentation		20/07/23	2.74MB	Share
SNT	PXS to Present at MST Access Biotech Hidden Gems Forum		18/07/23	187.17KB	Share
SNT	Investor Presentation MF 101 Interim Data		12/07/23	626.32KB	Share
SNT	Final Set of Interim Data from PXS-5505 in Myelofibrosis	PRICE SENSITIVE	12/07/23	245.37KB	Share
SNT	Application for quotation of securities - PXS		05/07/23	24.9KB	Share
SNT	Notification of cessation of securities - PXS		05/07/23	21.51KB	Share
SNT	Change in substantial holding		05/07/23	585.34KB	Share
SNT	Investor presentation		24/05/23	1.37MB	Share

SNT SNT to present in MST Access Hidden Gems Webinar
12/06/24		109.57KB	Share
SNT Change of registry address notification
24/05/24		88.49KB	Share
SNT Investor Webinar Presentation
17/05/24		107.34KB	Share
SNT Application for quotation of securities - SNT
30/04/24		15.66KB	Share
SNT Updated company investor presentation
30/04/24		938.01KB	Share
SNT Presentation for quarterly shareholder briefing
30/04/24		430.76KB	Share
SNT Quarterly Activities Report
30/04/24	PRICE SENSITIVE	201.7KB	Share
SNT Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	234.71KB	Share
SNT Notification of cessation of securities - SNT
29/04/24		12.73KB	Share
SNT SNT Quarterly Report and Investor Briefing
24/04/24		110.47KB	Share
SNT Change in substantial holding
15/04/24		170.12KB	Share
SNT Phase 2 Trial Reaches 50% Recruitment
10/04/24		123.17KB	Share
SNT Investor presentation - NWR Virtual Healthcare Conference
19/03/24		903.3KB	Share
SNT SNT to present at NWR Virtual Healthcare Conference
14/03/24		98.36KB	Share
SNT Investor Presentation
06/03/24		1.19MB	Share
SNT Change in substantial holding
04/03/24		665.93KB	Share
SNT Half Yearly Report and Accounts
29/02/24	PRICE SENSITIVE	792.29KB	Share
SNT Application for quotation of securities - SNT
29/02/24		15.67KB	Share
SNT Change of Director's Interest Notice
14/02/24		224.17KB	Share
SNT Change of Director's Interest Notice
14/02/24		225.86KB	Share
SNT Notification regarding unquoted securities - SNT
14/02/24		19.03KB	Share
SNT SNT to Trial New Cancer Indication Following MRFF Grant
14/02/24		117.23KB	Share
SNT Change in substantial holding
09/02/24		201.17KB	Share
SNT Application for quotation of securities - SNT
08/02/24		15.64KB	Share
SNT Change in substantial holding
07/02/24		184.65KB	Share
SNT Notification of cessation of securities - SNT
06/02/24		12.72KB	Share
SNT Notification of cessation of securities - SNT
06/02/24		12.75KB	Share
SNT Change of Director's Interest Notice
06/02/24		222.73KB	Share
SNT Section 708A(5)9e) Notice
06/02/24		116.16KB	Share
SNT Application for quotation of securities - SNT
06/02/24		15.33KB	Share
SNT Application for quotation of securities - SNT
06/02/24		15.6KB	Share
SNT Investor presentation - Euroz Hartley Healthcare Conference
06/02/24		920.77KB	Share
SNT Security Purchase Plan
02/02/24		103.06KB	Share
SNT Quarterly investor presentation
01/02/24		348.72KB	Share
SNT Results of Meeting
31/01/24		188.24KB	Share
SNT Quarterly Activities Report
31/01/24	PRICE SENSITIVE	343.15KB	Share
SNT Quarterly Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	223.07KB	Share
SNT Ceasing to be a substantial holder
23/01/24		218.61KB	Share
SNT Change in substantial holding
04/01/24		272.5KB	Share
SNT Change in substantial holding
03/01/24		272.41KB	Share
SNT Application for quotation of securities - SNT
02/01/24		24.91KB	Share
SNT Change in substantial holding
02/01/24		605.64KB	Share
SNT Change in substantial holding
29/12/23		179.6KB	Share
SNT Security Purchase Plan
29/12/23		645.88KB	Share
SNT Notice of General Meeting/Proxy Form
29/12/23		4.15MB	Share
SNT Section 708A(5)(e) Notice
27/12/23		397.23KB	Share
SNT Application for quotation of securities - SNT
27/12/23		24.8KB	Share
SNT Investor presentation - equity raising
19/12/23		1.6MB	Share
SNT Proposed issue of securities - SNT
19/12/23		35.5KB	Share
SNT Placement
19/12/23	PRICE SENSITIVE	367.31KB	Share
SNT Trading Halt
18/12/23	PRICE SENSITIVE	399.59KB	Share
SNT SNT doses first patient in Phase 2 combination MF trial
13/12/23		176KB	Share
SNT Constitution
08/12/23		381.63KB	Share
SNT Syntara Receives $5m R&D Tax Incentive
05/12/23		475.35KB	Share
SNT Change of Company Name
04/12/23		471.76KB	Share
SNT Change of Director's Interest Notice - GP
29/11/23		251.95KB	Share
SNT Notification regarding unquoted securities - PXS
29/11/23		25.13KB	Share
SNT Results of Meeting
28/11/23		353.47KB	Share
SNT CEO Presentation to AGM
28/11/23		1.22MB	Share
SNT Chair's Address to Shareholders
28/11/23		162.83KB	Share
SNT Application for quotation of securities - PXS
13/11/23		24.91KB	Share
SNT First patient dosed in Phase 2 trial of sleep disorder
09/11/23		493.58KB	Share
SNT Application for quotation of securities - PXS
06/11/23		24.91KB	Share
SNT Investor presentation - quarterly update
31/10/23		576.24KB	Share
SNT Quarterly Activities Report
31/10/23	PRICE SENSITIVE	818.62KB	Share
SNT Quarterly Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	402.52KB	Share
SNT PXS Quarterly Shareholder Update and Investor Call
30/10/23		181.32KB	Share
SNT Appendix 4G
26/10/23		253.7KB	Share
SNT Corporate Governance Statement
26/10/23		232.32KB	Share
SNT Annual Report to shareholders
26/10/23		1.26MB	Share
SNT Notice of Annual General Meeting/Proxy Form
26/10/23		845.73KB	Share
SNT Pharmaxis Completes Sale of Mannitol Business
19/10/23		183.67KB	Share
SNT Investor Presentation
17/10/23		1.8MB	Share
SNT Notification regarding unquoted securities - PXS
12/10/23		26.7KB	Share
SNT Notification of cessation of securities - PXS
06/10/23		21.54KB	Share
SNT Final Directors Interest Notice
03/10/23		115.8KB	Share
SNT Final Directors Interest Notice
03/10/23		116.87KB	Share
SNT Investor Presentation
03/10/23		1.65MB	Share
SNT PXS Company Restructure Sale of Mannitol Business
03/10/23	PRICE SENSITIVE	498.47KB	Share
SNT Trading Halt
02/10/23	PRICE SENSITIVE	556.33KB	Share
SNT Date of Virtual AGM Date for Receipt of Director Nominations
13/09/23		225.94KB	Share
SNT Application for quotation of securities - PXS
01/09/23		24.91KB	Share
SNT Nature Cancer Publishes Results of PXS Garvin Collaboration
29/08/23		257.28KB	Share
SNT Preliminary Final Report
28/08/23	PRICE SENSITIVE	2.05MB	Share
SNT Change in substantial holding
14/08/23		647.58KB	Share
SNT Application for quotation of securities - PXS
08/08/23		24.91KB	Share
SNT Notification of cessation of securities - PXS
08/08/23		21.51KB	Share
SNT PXS to Receive Prepayment of 2023 Research Tax Incentive
08/08/23	PRICE SENSITIVE	188.43KB	Share
SNT Quarterly Activities Report
31/07/23	PRICE SENSITIVE	643.63KB	Share
SNT Quarterly Appendix 4C Cash Flow Report
31/07/23	PRICE SENSITIVE	330.79KB	Share
SNT Pharmaxis Quarterly Shareholder Update and Investor Briefing
28/07/23		203.69KB	Share
SNT Ceasing to be a substantial holder
26/07/23		85.16KB	Share
SNT Investor Presentation
20/07/23		2.74MB	Share
SNT PXS to Present at MST Access Biotech Hidden Gems Forum
18/07/23		187.17KB	Share
SNT Investor Presentation MF 101 Interim Data
12/07/23		626.32KB	Share
SNT Final Set of Interim Data from PXS-5505 in Myelofibrosis
12/07/23	PRICE SENSITIVE	245.37KB	Share
SNT Application for quotation of securities - PXS
05/07/23		24.9KB	Share
SNT Notification of cessation of securities - PXS
05/07/23		21.51KB	Share
SNT Change in substantial holding
05/07/23		585.34KB	Share
SNT Investor presentation
24/05/23		1.37MB	Share

REFRESH

1 2 3 4 5 6

(20min delay)
Last 2.7¢		Change -0.001(3.57%)		Mkt cap ! $32.23M

Open	High	Low	Value	Volume
2.8¢	2.8¢	2.7¢	$2.232K	81.73K

Buyers (Bids)

No.	Vol.	Price($)
4	280000	2.6¢

Sellers (Offers)

Price($)	Vol.	No.
2.8¢	297894	2

View Market Depth

No.	Vol.	Price($)
4	280000	0.026
5	1279690	0.025
2	70002	0.024
2	239378	0.023
4	1017545	0.022

Price($)	Vol.	No.
0.028	297894	2
0.029	47870	1
0.030	358058	3
0.031	687842	2
0.032	200000	1

Last trade - 16.10pm 19/06/2024 (20 minute delay)


Last 2.7¢		Change -0.001 ( 3.85 %)
Open	High	Low	Volume
2.8¢	2.8¢	2.6¢	8912
Last updated 15.59pm 19/06/2024 ?

SNT (ASX) Chart

SYNTARA LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories